Lv52
1010 积分 2025-07-03 加入
Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future
19天前
已完结
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy
19天前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
25天前
已完结
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
2个月前
已完结
Prevention of heart failure after acute myocardial infarction
2个月前
已完结
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
3个月前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
3个月前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
3个月前
已关闭
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
3个月前
已关闭
Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
3个月前
已完结
皖公网安备34019202002308
